GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
86 hedge funds and large institutions have $618M invested in GenMark Diagnostics, Inc in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-4
Holders Change %
-4.44%
% of All Funds
2.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
30
Reduced
26
Closed
9
Calls
$66K
Puts
–
Net Calls
+$66K
Net Calls Change
-$123K
Top Buyers
| 1 |
BlackRock
New York
|
+$38M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$8.33M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$5.16M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4.17M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$4.01M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$13.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.56M |
| 3 |
Jennison Associates
New York
|
-$1.59M |
| 4 |
CC
Casdin Capital
New York
|
-$1.41M |
| 5 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
-$1.33M |
